🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

ATI Physical Therapy stock target raised, hold rating reiterated by Jefferies

EditorNatashya Angelica
Published 08/06/2024, 08:20 PM
ATIP
-

On Tuesday, Jefferies maintained a Hold rating on shares of ATI Physical Therapy (NYSE:ATIP) and increased the price target to $5.50 from the previous $5.30. The firm acknowledged the company's strong performance in the second quarter, which featured a notable rise in both service volumes and rates. ATI Physical Therapy reported a 6.4% increase in volumes and a 3.4% rise in rates, leading to a substantial earnings beat.

The company's earnings before interest, taxes, depreciation, and amortization (EBITDA) exceeded Wall Street expectations by 16%. Furthermore, free cash flow (FCF) demonstrated a significant quarter-over-quarter improvement of 40%. These figures reflect the company's successful efforts in enhancing its operational efficiency during the quarter.

Despite the positive operational results, Jefferies pointed out that ATI Physical Therapy's highly leveraged balance sheet poses challenges for substantial stock appreciation. The current market conditions, which typically penalize companies with high levels of debt, add to the firm's cautious stance on the stock's near-term growth potential.

ATI Physical Therapy's recent financial achievements indicate progress in management's strategies to improve operations. However, the company's financial structure, characterized by considerable leverage, remains a concern, particularly in a volatile market environment that often disfavors such financial profiles.

The updated stock price target of $5.50 reflects Jefferies' recognition of ATI Physical Therapy's operational improvements, yet it also underscores the financial headwinds faced by the company due to its balance sheet. The Hold rating suggests that while the firm sees value in the company's recent developments, it also advises caution due to the associated financial risks.

In other recent news, ATI Physical Therapy has delivered a robust start to 2024 with an 8.7% year-over-year increase in net revenue, amounting to $181 million in Q1. This positive trend is partly due to a daily surge of approximately 1,100 patient visits and a 4.5% rise in the rate per visit. However, the company is grappling with escalating costs owing to wage inflation and is devising strategies to enhance financial performance and widen access to care.

Net patient revenue also saw a 9.7% year-over-year increase, reaching $165 million. Meanwhile, salaries and related costs escalated to $99 million, and other operational expenses rose to $55 million. The company anticipates Q2 to generate between $185 million and $195 million in revenue and an adjusted EBITDA of $15 million to $20 million.

ATI Physical Therapy continues to streamline its real estate assets, recently closing 11 clinics and divesting one. The company is also concentrating on expanding its workers' compensation and API segments and has mostly concluded payer negotiations for 2024. These are part of the recent developments that the company has experienced.

InvestingPro Insights

As ATI Physical Therapy (NYSE:ATIP) navigates through its operational enhancements, real-time data from InvestingPro provides a more granular look into the company's financial health. The market cap stands at a modest $28.31 million, reflecting the size of the company within its industry.

Despite the reported progress in operations, ATI Physical Therapy's P/E ratio remains negative at -0.22, indicating that the market currently does not expect earnings to cover the share price. This aligns with the caution expressed by Jefferies regarding the company's highly leveraged financial position.

On a positive note, ATI Physical Therapy has demonstrated a robust revenue growth of 10.31% over the last twelve months as of Q1 2024, which could be a sign of the company's potential to scale operations and improve financial outcomes. Moreover, the company has achieved an impressive EBITDA growth of 181.5% in the same period, potentially signaling operational efficiency gains. These metrics may offer some optimism for investors looking at the company's ability to generate earnings before interest, taxes, depreciation, and amortization.

InvestingPro Tips highlight that management's aggressive share buybacks could indicate their confidence in the company's future, while the significant debt burden and the quick cash burn rate remain areas of concern. Analysts do not expect the company to be profitable this year, and ATI Physical Therapy does not pay a dividend, which may influence investment decisions for those seeking income. For those interested in a deeper analysis, InvestingPro offers additional tips on the company's financials and performance.

In the context of ATI Physical Therapy's recent financial results and Jefferies' rating, these InvestingPro Data metrics and Tips provide valuable insights for investors considering the company's stock. They underscore the importance of balancing operational successes with the realities of the company's financial structure. For further guidance, investors can explore the full range of 10 InvestingPro Tips available for ATI Physical Therapy at https://www.investing.com/pro/ATIP.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.